1. Articles in category: News

    97-120 of 185 « 1 2 3 4 5 6 7 8 »
    1. Beliefs about complementary and alternative medicine predict use among patients with cancer

      A new study has shed light on how cancer patients' attitudes and beliefs drive the use of complementary and alternative medicine. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings may help hospitals develop more effective and accessible integrative oncology services for patients. Although many cancer patients use complementary and alternative medicine, what drives this usage is unclear.

      Read Full Article
    2. Microfluidic Cell-Squeezing Device Opens New Possibilities for Cell-Based Vaccines

      "Using a microfluidic device, MIT researchers were able to overcome this genetically programmed barrier to antigen uptake — by squeezing the B cells.  Through “CellSqueeze,” the device platform originally developed at MIT, the researchers pass a suspension of B cells and target antigen through tiny, parallel channels etched on a chip. A positive-pressure system moves the suspension through these channels, which gradually narrow, applying a gentle pressure to the B cells. This “squeeze” opens small, temporary holes in their membranes, allowing the target antigen to enter by diffusion."

      Read Full Article
    3. Blood to Feeling: McMaster Scientists Turn Blood into Neural Cells

      Hamilton, ON (May 21, 2015) - Scientists at McMaster University have discovered how to make adult sensory neurons from human patients simply by having them roll up their sleeve and providing a blood sample. Specifically, stem cell scientists at McMaster can now directly convert adult human blood cells to both central nervous system (brain and spinal cord) neurons as well as neurons in the peripheral nervous system (rest of the body) that are responsible for pain, temperature and itch perception.

      Read Full Article
    4. Old drug may bring new hope to young cancer patients

      Old drug may bring new hope to young cancer patients

      "DFMO is really exciting because of its ability to hopefully prevent relapse. To be able to stop that relapse, to be able to even postpone it until we find a front line cure is incredible," Kyle said.  Even though the drug is still experimental for neuroblastoma, it's showing promise.  Through the Tampa based foundation "Because of Ezra", Kyle and his wife Robyn, are now dedicating their lives to bringing this new option to other families. According to their website, the foundation has raised $400,000 to help fund clinical trials across the world combating neuroblastoma. Soon there will be ...

      Read Full Article
    5. Europe OKs First PD-Inhibitor, Nivolumab

      Nivolumab (Opdivo, Bristol-Myers Squibb Company) becomes the first programmed-death (PD) immune checkpoint inhibitor immunotherapy to be recommended for approval in Europe.

      The European Medicines Agency has recommended approval of the drug for use as first-line treatment and also for use in previously treated patients with advanced (unresectable or metastatic) melanoma.

      Read Full Article
    6. Inflammation-cancer feedback loop discovery is a step toward better cancer drugs

      Inflammation-cancer feedback loop discovery is a step toward better cancer drugs

      "In order to pinpoint this altered pro-inflammatory mechanism in cancer cells, Dr. Cascio and her team combed through more than 20 types of epigenetic modifications and 300 factors that allow for the remodeling of chromatin, which are macromolecules in cells that control gene expression and DNA replication.  Specifically, the researchers found that MUC1 and p65 involve an enzyme called the Enhancer of Zeste homolog 2, or EzH2, known to induce epigenetic modifications, in order to prompt chromatin remodeling on cytokine gene promoters.  "Developing drugs that could keep these genes from being improperly turned on and off could interrupt this cancer-inflammation ...

      Read Full Article
    7. Scientists Discover Protein That Boosts Immunity to Viruses And Cancer

      "Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies.  Experiments in mice and human cells have shown that the protein promotes the proliferation of cytotoxic T cells, which kill cancer cells and cells infected with viruses. The discovery was unexpected because the new protein had no known function and doesn't resemble any other protein.  Researchers from Imperial College London who led the study are now developing a gene therapy designed to boost the infection-fighting cells, and hope to begin human trials in three years."

      Read Full Article
    8. Developing a healthy web-based cookbook for pediatric cancer patients and survivors: rationale and methods.

      Developing a healthy web-based cookbook for pediatric cancer patients and survivors: rationale and methods.

      Developing a healthy web-based cookbook for pediatric cancer patients and survivors: rationale and methods.

      JMIR Res Protoc. 2015;4(1):e37

      Authors: Li R, Raber M, Chandra J

      Abstract BACKGROUND: Obesity has been a growing problem among children and adolescents in the United States for a number of decades.

      Read Full Article
    9. Team of Australian experts undertake pioneering approach to aggressive cancers

      Team of Australian experts undertake pioneering approach to aggressive cancers

      “One of the biggest challenges we face in cancer treatment is the toxicity of standard chemotherapy towards normal cells, which can lead to terrible side-effects and life-long health issues for cancer survivors,” continues Professor Kavallaris.  “This program will investigate the development of nanotechnology for less invasive methods to diagnose and treat cancer.”

      Read Full Article
    10. Old Blood as Good as Fresh in Patients with Life-threatening Illnesses

      "Blood transfusions save lives, affirm the authors. There is no need to worry about the safety of the age of blood routinely used in hospitals. The same research team is conducting a clinical trial in pediatric patients. "This study should verify whether children react to fresh blood and older blood transfusions in the same way as adults", said Dr. Jacques Lacroix of the Sainte-Justine University Hospital Research Center and professor at the Université de Montréal."

      Read Full Article
    11. Raw Data: Cancer Can Be Tough Case to Prove

      Raw Data: Cancer Can Be Tough Case to Prove

      The genetic mutations that cause cancer can take decades to manifest themselves.

      Last month, thousands of Marines and their families were blocked in federal court from pursuing their claim that the government had given them cancer. The decision, involving people exposed to contaminated drinking water while stationed at Camp Lejeune, a base in North Carolina, didn’t consider the science ...

      Read Full Article
    97-120 of 185 « 1 2 3 4 5 6 7 8 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles